Q4 2017 Sentiment Biolase Inc (NASDAQ:BIOL)

April 21, 2018 - By Marie Mckinney


Sentiment for Biolase Inc (NASDAQ:BIOL)

Biolase Inc (NASDAQ:BIOL) institutional sentiment increased to 1.31 in 2017 Q4. Its up 0.52, from 0.79 in 2017Q3. The ratio is better, as 17 investment managers increased and opened new holdings, while 13 sold and decreased their positions in Biolase Inc. The investment managers in our partner’s database now have: 36.99 million shares, up from 29.45 million shares in 2017Q3. Also, the number of investment managers holding Biolase Inc in their top 10 holdings was flat from 1 to 1 for the same number . Sold All: 7 Reduced: 6 Increased: 11 New Position: 6.

BIOLASE, Inc., a medical device company, develops, makes, markets, and sells laser systems in dentistry and medicine in the United States and internationally. The company has market cap of $33.26 million. The firm offers Waterlase dental laser systems for cutting soft and hard tissue; and diode laser systems, which are used to perform soft tissue, pain therapy, and cosmetic procedures, including teeth whitening. It currently has negative earnings. The Company’s dental laser systems allow dentists, periodontists, endodontists, oral surgeons, and other dental specialists to perform a range of dental procedures, such as cosmetic, restorative, and complex surgical applications.

The stock decreased 1.43% or $0.005 during the last trading session, reaching $0.325. About 153,686 shares traded or 9.64% up from the average. BIOLASE, Inc. (NASDAQ:BIOL) has declined 67.19% since April 21, 2017 and is downtrending. It has underperformed by 78.74% the S&P500.

Oracle Investment Management Inc holds 2.61% of its portfolio in BIOLASE, Inc. for 30.87 million shares. Trellus Management Company Llc owns 577,354 shares or 0.34% of their US portfolio. Moreover, Birchview Capital Lp has 0.32% invested in the company for 1.29 million shares. The New York-based Teton Advisors Inc. has invested 0.02% in the stock. Bank Of America Corp De, a North Carolina-based fund reported 1,964 shares.

BIOLASE, Inc. (NASDAQ:BIOL) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: